share_log

Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals

Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals

预测未来:14位分析师对Rhythm Pharmaceuticals的预测
Benzinga ·  12/20 06:00
Ratings for Rhythm Pharmaceuticals (NASDAQ:RYTM) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中,14位分析师对Rhythm Pharmaceuticals(纳斯达克:RYTM)进行了评级,展现出看好和看淡的不同观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们近期的评级,展示了过去30天内情绪的变化,并与之前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $67.36, a high estimate of $80.00, and a low estimate of $52.00. This upward trend is evident, with the current average reflecting a 6.5% increase from the previous average price target of $63.25.
分析师评估的12个月价格目标提供了进一步的见解,平均目标为67.36美元,最高估计为80.00美元,最低估计为52.00美元。这个上升趋势很明显,目前的平均值反映出比之前的平均价格目标63.25美元增加了6.5%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查:一项详尽的研究
A comprehensive examination of how financial...
对财务专家如...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发